Brain perfusion and ultrasonic imaging techniques

Jens Eyding , Wilko Wilkening , Thomas Postert
{"title":"Brain perfusion and ultrasonic imaging techniques","authors":"Jens Eyding ,&nbsp;Wilko Wilkening ,&nbsp;Thomas Postert","doi":"10.1016/S0929-8266(02)00042-3","DOIUrl":null,"url":null,"abstract":"<div><p>Advances in neurosonology have generated several techniques of ultrasonic perfusion imaging employing ultrasound echo contrast agents (ECAs). Doppler imaging techniques cannot measure the low flow velocities that are associated with parenchymal perfusion. Ultrasonic perfusion imaging, therefore, is a combination of a contrast agent-specific ultrasound imaging technique (CAI) mode and a data acquisition and processing (DAP) technique that is suited to observe and evaluate the perfusion kinetics. The intensity in CAI images is a measure of ECA concentration but also depends on various other parameters, e.g. depth of examination. Moreover, ECAs can be destroyed by ultrasound, which is an artifact but can also be a feature. Thus, many different DAPs have been developed for certain CAI techniques, ECAs and target organs. Although substantial progress in ECA and CAI technology can be foreseen, ultrasound contrast imaging has yet to reliably differentiate between normal and pathological perfusion conditions. Destructive imaging techniques, such as contrast burst imaging (CBI) or time variance imaging (TVI), in combination with new DAP techniques provide sufficient signal-to-noise ratio (SNR) for transcranial applications, and consider contrast agent kinetics and destruction to eliminate depth dependency and to calculate semi-quantitative parameters. Since ultrasound machines are widely accessible and cost-effective, ultrasonic perfusion imaging techniques should become supplementary standard perfusion imaging techniques in acute stroke diagnosis and monitoring. This paper gives an overview on different CAI and DAP techniques with special focus on recent innovations and their clinical potential.</p></div>","PeriodicalId":79592,"journal":{"name":"European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology","volume":"16 1","pages":"Pages 91-104"},"PeriodicalIF":0.0000,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0929-8266(02)00042-3","citationCount":"37","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0929826602000423","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 37

Abstract

Advances in neurosonology have generated several techniques of ultrasonic perfusion imaging employing ultrasound echo contrast agents (ECAs). Doppler imaging techniques cannot measure the low flow velocities that are associated with parenchymal perfusion. Ultrasonic perfusion imaging, therefore, is a combination of a contrast agent-specific ultrasound imaging technique (CAI) mode and a data acquisition and processing (DAP) technique that is suited to observe and evaluate the perfusion kinetics. The intensity in CAI images is a measure of ECA concentration but also depends on various other parameters, e.g. depth of examination. Moreover, ECAs can be destroyed by ultrasound, which is an artifact but can also be a feature. Thus, many different DAPs have been developed for certain CAI techniques, ECAs and target organs. Although substantial progress in ECA and CAI technology can be foreseen, ultrasound contrast imaging has yet to reliably differentiate between normal and pathological perfusion conditions. Destructive imaging techniques, such as contrast burst imaging (CBI) or time variance imaging (TVI), in combination with new DAP techniques provide sufficient signal-to-noise ratio (SNR) for transcranial applications, and consider contrast agent kinetics and destruction to eliminate depth dependency and to calculate semi-quantitative parameters. Since ultrasound machines are widely accessible and cost-effective, ultrasonic perfusion imaging techniques should become supplementary standard perfusion imaging techniques in acute stroke diagnosis and monitoring. This paper gives an overview on different CAI and DAP techniques with special focus on recent innovations and their clinical potential.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脑灌注和超声成像技术
神经超声学的进步产生了几种超声灌注成像技术,采用超声回声造影剂(ECAs)。多普勒成像技术不能测量与实质灌注相关的低血流速度。因此,超声灌注成像是一种结合了造影剂特异性超声成像技术(CAI)模式和数据采集和处理(DAP)技术的技术,适合于观察和评估灌注动力学。CAI图像中的强度是ECA浓度的量度,但也取决于各种其他参数,例如检查深度。此外,eca可以被超声波破坏,这是一种人工制品,但也可以是一种特征。因此,针对某些CAI技术、eca和靶器官开发了许多不同的dap。虽然可以预见ECA和CAI技术的实质性进展,但超声对比成像尚未可靠地区分正常和病理灌注情况。破坏性成像技术,如对比爆发成像(CBI)或时间方差成像(TVI),与新的DAP技术相结合,为经颅应用提供了足够的信噪比(SNR),并考虑了造影剂动力学和破坏,以消除深度依赖和计算半定量参数。由于超声仪器的广泛使用和成本效益,超声灌注成像技术应成为急性卒中诊断和监测的补充标准灌注成像技术。本文概述了不同的CAI和DAP技术,特别关注最近的创新及其临床潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ultrasound assessment of the intima and media layers on the carotid arteries in peri- and postmenopausal women Subject Index Author Index Control system analysis of visually evoked blood flow regulation in humans under normocapnia and hypercapnia Effect of hypertension and candesartan on the blood flow velocity of the extraocular vessels in hypertensive patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1